A Highly Sensitive Next-Generation Sequencing-Based Genotyping Platform for EGFR Mutations in Plasma from Non-Small Cell Lung Cancer Patients

SIMPLE SUMMARY: In this study, Sel-Cap(TM), a next-generation sequencing (NGS)-based genotyping platform, showed high sensitivity for detection of epidermal growth factor receptor (EGFR) gene mutations in plasma samples collected from 185 patients with non-small cell lung cancer (NSCLC). In the earl...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Jung-Young, Kim, Jeong-Oh, Lee, Mi-Ran, Kim, Seo Ree, Beck, Kyongmin Sarah, Kang, Jin Hyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760633/
https://www.ncbi.nlm.nih.gov/pubmed/33266057
http://dx.doi.org/10.3390/cancers12123579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760633/
https://www.ncbi.nlm.nih.gov/pubmed/33266057
http://dx.doi.org/10.3390/cancers12123579

Ejemplares similares